CHEMO PHARMA LABORATORIES LTD. - 506365 - Submission Of Un-Audited Financial Results For The Quarter And Half Year Ended September 30, 2022
Approval of Un-Audited Financial Results of the Company for the quarter and half year ended September 30, 2022 along with the Limited Review Report thereon. CHEMO PHARMA LABORATORIES LTD. - 506365 - Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday, October 20, 2022
Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), we wish to inform you that the Board of Directors of the Company at their meeting held today, i.e. October 20, 2022, approved the Un-Audited Financial Results of the Company for the quarter and half year ended September 30, 2022 along with the Limited Review Report thereon. We are enclosing herewith, a copy of the Un-Audited Financial Results for the quarter and half year ended September 30, 2022 along with the Limited Review Report thereon by the auditor and cash flow statement and statement of assets and liabilities for the half year ended on 30th September, 2022. The Meeting commenced at 04.00 p.m. and concluded at 04.55 p.m. CHEMO PHARMA LABORATORIES LTD. - 506365 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding the issue of Duplicate Share Certificate under Regulation 39(3) of SEBI (Listing Obligation and Disclosure requirement), Regulation, 2015 CHEMO PHARMA LABORATORIES LTD. - 506365 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Thursday, October 20, 2022
CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/10/2022 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirement) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the Company will be held on Thursday, October 20, 2022 at 04:00 p.m. at the Corporate Office situated at Empire House, 214, Dr. D.N. Road, Fort, Mumbai - 400 001, inter alia, to consider and approve the Un-Audited Financial Statements for the quarter and half year ended September 30, 2022 along with the Limited Review Report thereon. CHEMO PHARMA LABORATORIES LTD. - 506365 - Statement Of Investor Complaints For The Quarter Ended September 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Ashok SomaniDesignation :- Chief Financial Officer CHEMO PHARMA LABORATORIES LTD. - 506365 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, we hereby submit the confirmation certificate for the quarter ended September 30, 2022 issued by Company's Registrar and Share Transfer Agent (RTA), i.e. M/s. Purva Sharegistry (India) Private Limited thereby confirming the compliances under the said regulation. CHEMO PHARMA LABORATORIES LTD. - 506365 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding issue of Duplicate Share Certificate under Regulation 39(3) of SEBI (Listing Obligation and Disclosure requirement), Regulation, 2015 CHEMO PHARMA LABORATORIES LTD. - 506365 - Closure of Trading Window
Pursuant to the provisions of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulation 2015 and Company's Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons, we hereby inform that the Trading Window of the Company shall remain closed for all the Designated Persons and their relatives with effect from October 01, 2022 till 48 hours after the financial results of the Company for the quarter ended September 30, 2022 becomes generally available information. CHEMO PHARMA LABORATORIES LTD. - 506365 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Chemo Pharma Laboratories Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here CHEMO PHARMA LABORATORIES LTD. - 506365 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Voting Results and Scrutinizer's Report of the 80TH Annual General Meeting as per Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements), 2015